Is pulmonary arterial hypertension associated with interferon-β therapy for multiple sclerosis reversible? A case study to explore the complexity.

Anastasia AnthiEleni StagakiLoukianos RallidisDimitrios KonstantonisMaria-Eleftheria EvangelopoulosKonstantinos VoumvourakisApostolos ArmaganidisStylianos E Orfanos

Published in: ERJ open research (2020)

The possible causal relationship between interferon-β exposure and pulmonary arterial hypertension development requires close follow-up of patients on treatment with interferon-β http://bit.ly/2OPGSVP.

Keyphrases

pulmonary arterial hypertension
pulmonary artery
pulmonary hypertension
multiple sclerosis
dendritic cells
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
prognostic factors
coronary artery
white matter